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We have become a society of convenience. Healthy foods that were staples for thousands of 
years have become replaced by processed foods with long shelf lives. This has been done to the 
detriment of our nutrition and health. Flax is one such replaced food item. A staple food for 
hundreds of generations, flax had become scarce in our diet until recent interest spurred by 
research found flax to be one of the best sourc es on earth for alpha-linolenic acid an Omega- 
three fatty acid, plant lignans, and contains a large amount of dietary fiber. Potentially these 
constituents can have great health benefits for many health disparities such as cardiovascular 
disease including hypercholesterolemia, as well as, conditions such as cancer, inflammation, and 
bowel regulation.
The purpose of doing this review is to identify the proven benefits of flax supplementation to use 
in primary care. The main search engines used to search the literature included PubMed, 
CINAHL, and Google Scholar. The literature shows flax supplementation has proven LDL 
cholesterol lowering benefits, bowel regulation benefits, inflammatory marker reduction, and 
enormous potential for further research in many other areas. For this reason it is appropriate in 
primary practice to support flax supplementation to promote normal cholesterol levels, and for 
bowel regulation.
Key Words: lignans, flax, flaxseed, Omega-three Fatty acids, cholesterol, ALA, and
cardiovascular disease
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A Review of the Benefits of Flax Supplementation 
Cardiovascular disease is prevalent in our society with 26.6 million diagnosed as having heart 
disease in the United States (CDC Fast Stats). This is due in part to diets high in Omega-six fatty 
acids found in animal derived meat and fats. During the past decade studies have found that 
supplementing the diet with foods rich in Omega-three fatty acids can help reduce the risk of 
cardiovascular disease. Fish oil is one such food that is high in Omega-three fatty acids; however 
there are concerns about the fish taste contained in fish oil supplements, industrial overfishing, 
and contaminants such as mercury found in fish. For those who want an alternative to fish oil, 
there is a common agricultural product that may also have cardioprotective Omega-three fatty 
acids, anti-inflammatory lignans, and beneficial fiber. This product is flax.
Flax is a grain that has been grown domestically since at least 8000 BC. (NDSU, 2007). It has 
been touted as a health food for hundreds of years; in the ninth century the Roman Emperor 
Charlemagne believed in the benefits of flax so much that he enacted a law to force its 
consumption among his constituents (Children’s Better Health Institute, 2005). The seeds can be 
eaten whole or milled into flour, and the plant itself is very durable. In fact, flax has been used 
to make linen and is currently used to make cigarette paper, due to its durability in thin layers.
Flax seeds are very high in fiber, protein, magnesium, thiamine, plant lignans, and Omega- 
three fatty acids in the form of Alpha-linolenic-acid (ALA) (Buse, et al., 2009). ALA is one of 
only two essential fatty acids, meaning that it is needed by the body, however, the body is not 
able to produce it. In order to be utilized, ALA must be converted to eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA) in the body (Consumer Reports on Health, 2009). Fish 
oils are already high in the fatty acids EPA and DHA, but do not contain any fiber or plant
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lignans. Current studies on ALA attempt to not only determine the amount of ALA that is able to 
be converted by the body, but also determine whether ALA has the benefits of EPA and DHA on 
its own. In addition, there are questions about the potential benefits of the fiber and plant lignans 
found in flax. This paper will attempt to identify the proven benefits of flaxseed product 
supplementation.
Purpose
This independent study on flax supplementation will review the current literature in order to 
fully understand the proven benefits of dietary supplementation with flaxseed and flax derived 
products. The health aspects looked at for the use of flax supplementation include cardiovascular 
health, type 2 diabetes mellitus, prostate cancer, inflammation, menopausal symptoms, and 
bowel management. ALA, fiber, and lignans are the three components of flaxseed that will be 
the focus of this review.
After completing this review, an educational pamphlet was created for use in clinical settings 
to discuss the research findings on flax supplementation (see Appendix B). If the findings are 
beneficial, methods in which to add flax to the diet, for example adding a tablespoon of ground 
flax to oatmeal or yogurt, or potential ways to use flax in baking, may be included. The potential 
recommendations for or against flax supplementation will be used for personal supplementation, 
as well as, for future patients, colleagues, and family members. If there is not sufficient evidence 
to support supplementation, or the evidence is not in favor of supplementation, flax 
supplementation will not be recommended.
Significance
This study has the potential to impact nursing science and practice in a positive way by 
improving the health of our patients. The science of nursing is a science that has health
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promotion at its core. It focuses on taking a primary preventative approach to illness rather than a 
tertiary treatment approach. Dietary modification can affect several levels of prevention, it can 
be used to help prevent disease altogether, or it can be used to maintain and improve disease 
processes already at play. Flax supplementation could be one such dietary modification with 
preventative and treatment properties. Some of the potentially beneficial ingredients include a 
high amount of fiber, both soluble and insoluble, high concentrations of ALA omega-three fatty 
acid, and antioxidant plant lignans of which flax has 800 times the amount of lignans found in 
most other foods (Demark-Wahnefried, 2008). If flaxseed supplementation is effective at 
improving health or quality of life, it has the potential to affect all areas of health care for the 
prevention and treatment of disease.
This study is important in that it will demonstrate the potential benefits and or detriments of 
flax supplementation. With Cardiovascular disease consistently being a leading cause of 
mortality in the United States, a natural method of potential prevention is immensely important. 
This is especially true when the method of prevention is generally easy, such as eating or taking 
a supplement. If supplementation of flax may have the ability to help prevent cardiovascular 
disease like fish oil, but does not have the mercury contamination, bad taste, or allergenic affect, 
people may be more apt to adhere to a flax regimen. Also, there are a number of potential 
benefits of the fiber in flax. Much of the population requires fiber supplementation and or 
laxative use in order to maintain regularity of bowel movements and prevent constipation. Flax 
could potentially solve this problem without unnatural, and possibly detrimental, pharmacologic 
interventions. In addition, flax lignans have the potential to act as antioxidants that could prove 
to have many potential benefits, the extent of which are unknown.
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While this study will not generate new results or uses for flax, it will compile the results 
already available making them easier to compare and contrast. In addition, it will help to 
determine the proven benefits of flax, the quality and reliability of the current information, and 
whether there is a need for further study before determinations on flax supplementation can be 
made.
Theoretical Framework
The theoretical framework used for this review is based on Betty Neumann’s Systems model. 
This model uses the concepts of client whol eness, the goal of optimal health and utilization of 
primary prevention strategies to maintain wellness (Neumann & Reed, 2007). This model’s focus 
is not only on prevention, but also on stress, reaction to stress, and the constant continuum 
towards and away from health and illness (Western Governor’s University College of Health, 
2011).
Neumann’s continuum of illness and wellness is influenced by factors such as diet. Dietary 
intake can have positive or negative impact on health by influencing cholesterol, laxation, and 
inflammation. In the absence of disease, flax supplementation has the potential to provide a 
positive mode of primary prevention by maintaining normal cholesterol levels, normal healthy 
laxation, and potentially preventing inflammation and the numerous health disparities associated 
with inflammation. In the presence of disease, flax supplementation can provide tertiary 
prevention, which involves treating conditions such as hypercholesterolemia by reducing 
cholesterol, constipation by increasing ease of laxation, and conditions characterized and 
exacerbated by inflammation. In either circumstance, flax supplementation has the potential to 




In writing this review there are several terms that require definition and clarification in order 
to achieve understanding of the concepts inclu ded. These terms include Omega three fatty acids, 
Alpha-linolenic acid (ALA), Eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA), fiber, 
and lignans.
1) Omega-three fatty acids: are polyunsaturated fats derived from fish and many plant sources 
such as flax, sunflower, com, soybeans, olives, and canola.
2) ALA: Alpha-linolenic acid (ALA) is an essential omega-three fatty acid found in high 
concentrations in flaxseed oil. There are questions about whether or not ALA has any beneficial 
health effects in the body, or if it needs to be converted to EPA and then DHA before it can be 
beneficial.
3) EPA: Eicosapentaenoic acid is a beneficial Omega-three fatty acid found in fish oil. EPA 
can be converted to DHA, which is proven to be more beneficial than EPA. Some evidence 
exists that ALA is able to be converted to EPA and DHA.
4) DHA: Docosahexaenoic acid (DHA) is an Omega-three fatty acid, a polyunsaturated fatty 
acid, which studies show to be responsible for the antiatherogenic abilities of fish oil (Alternative 
Medicine Review, p. 391). It has also been established as the fatty acid responsible for raising 
HDL cholesterol, and lowering LDLs and triglycerides.
5) Fiber: fiber is found in most plant products. It is indigestible and helps prevent constipation 
by adding bulk to the stool and aiding in defecation. The fiber content of flax is 28% by weight, 
33% of which is soluble fiber, which may have the potential to improve insulin sensitivity and 
lower cholesterol (Bloedon, 2008). Soluble fiber attracts water, turning into a gel in the GI tract 
which adds to bulk and aids motility of the stool.
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6) Lignans: lignans are compounds that naturally occur in plants. Some plant lignans can be 
converted into enterolignans by intestinal flora and absorbed in the blood stream. Studies 
suggested that high serum concentrations of enterolactone, an enterolignan, are associated with a 
lower risk of acute coronary events. “Associations between enterolignans and cancer are less 
clear,” (Kuijsten, Arts, Van’t Veer, & Hollman, 2005, p. 2812 ). “Among foods consumed by 
humans, flaxseed contains the highest concentration of enterolignan precursors,” (Kuijsten, et al., 




The majority of flax supplementation research has been done with the focus on 
cardiovascular health. In 2008, Bloedon set out to research the effects of flax compared to the 
effect of wheat bran supplementation on fasting lipoproteins, insulin resistance, inflammatory 
markers, and oxidative stress. Patade (2008) has also conducted research to determine whether 
30g of flaxseed would have an effect on the lipid profiles of postmenopausal Native American 
women. Lucas conducted a study in 2007 with the goal of comparing the cholesterol and lipid 
lowering cardiovascular benefits of 40g ground flax supplementation to the benefits of ground 
wheat. Lucas also set out to determine whether there were estrogenic or anti-estrogenic effects of 
the lignans, which potentially could have anti-osteoporotic benefits. Dodin, Lemny, Jacques, 
Legare, and Masse also attempted to find the effect of lignans on lipids, as well as, the 
phytoestrogenic effect from flaxseed supplementation (2005).
Several other studies have been done on the efficacy of differing types of flax 
supplements. One such study by Austria et al. (2008) was focused on determining the efficacy of
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absorption with the different modes of flax supplementation using 6g flax oil, 30g milled flax 
seed, or 30g whole flax seed. The intent was to determine the best method of supplementation 
with regards to ALA absorption, in addition to the effects of each product on cholesterol lipids 
and platelet aggregation. Some of the studies have been done using flax oil supplements alone. 
Barcelo-Coblijn et al. (2008) conducted a study in Winnipeg, Manitoba with assistance from the 
University of North Dakota which compared the effects of fish oil to flaxseed oil in varying 
amounts. This study was done with firemen who were at risk for cardiovascular disease (CVD).
Flax studies have been done to determine benefits for conditions other than CVD as well. 
Demark-Wahnefried (2008) produced a study to determine the effect of flax supplementation on 
prostate cancer proliferation in patients diagnosed with prostate cancer awaiting prostatectomy. 
This arose because flax is a substantial source of fiber and plant lignans, which may have 
“antimitotic, antiangiogenic, antioxidant and phytoestrogenic effects” which could be beneficial 
to cancer patients (Demark-Wahnefried, 2008, p. 3577). Hallund studied the effects of plant 
lignan supplementation on markers for vasoconstriction and inflammation (2006). Another study 
regarding the benefits of flax lignans by Pan et al. was to determine the effects of flax lignans on 
people with type 2 diabetes mellitus, based on the protective antioxidant effects associated with 
lignans (2007). Dares-Dobbie conducted a study on bowel movement patterns and the need for 
pharmacologic laxative interventions while supplementing nursing home residents’ food with 
ground flax. This was done to see whether large amounts of fiber, both soluble and insoluble, 
would decrease the incidence of constipation (2006). Wang’s study focused on determining 
whether the bacteria in the human GI tract could effectively convert the lignans to a more bio- 
available form to be used in the body (2010).
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Designs
Of the 12 clinical studies used in this review, all but two of them were double blind 
randomizd controlled clinical trials in which a control group was used, as well as, at least one 
flax supplement group. Of these, one was a randomized, double-blind, cross-over study in which 
each group took an eight week stent of being the control group. The amount of flax 
supplemented in these studies ranges from 30-40g of whole flaxseed or ground/milled flax, or 
1.2-6g flax oil and 360 -500 mg flax derived lignan supplement. In most of the studies, the flax 
products were used in baked goods to improve adherence and hide the identity of each groups’ 
supplement. The durations of these studies varied; a presurgical study averaged 21 days, 
although most were 10-12 weeks, and one lasted a full year. All studies involved periodic blood 
sampling alone and some used urine collection in addition to measure lignan metabolites to 
determine adherence to the diet.
There were two studies in the review that were not randomized controlled trials, they were, 
however, repeatable clinical trials. One study involved the effect of incorporation of flax into the 
diet on bowel habits. For this study, the design was to record normal bowel habits and 
pharmacologic interventions for one month. Then, two months later, flax was added to the diet 
and bowel habits and interventions were recorded again for another month. This group was 
supplemented with two tablespoons of flaxseed every morning. Blood testing was not done in 
this study. The other non-randomized study took fecal samples from healthy young adults and 
colonized the bacteria, combining the bacteria with flax lignans to determine whether the GI 
flora could convert them to more potent and bio-available lignans.
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Samples
According to Pan (2007), a sample of 67 was needed to maintain a one sided, 5% 
significance level for his crossover trial to allow for the chance of a 10% dropout rate. Sixty 
eight participants completed the Pan study. No other researchers reported the number of 
participants needed to maintain significance in their studies. Several of the studies had less than 
55 participants; one was Austria’s study in which there were only 30 participants separated into 
three groups, Dares-Dobbie’s (2006) study on constipation which included only 12 participants, 
and Hallund, Tetens, Bugel, Tholstrup and Brunn’s (2008) study which included only 22 healthy 
postmenopausal participants. The study by Dodin (2005) included the most participants with 
199 healthy postmenopausal women starting the study and 179 finishing the study. Demark - 
Wahneffied (2008) had the second largest number of participants with 161 starting the study and 
149 qualifying to finish the study. In several studies approximately 10% either did not return, 
dropped out, or were eliminated after being judged to have not adhered to the diet according to 
self reporting questionnaires and urine testing. The following inclusion criteria were used for 
many of the studies: age, menopausal status, cholesterol and lipid levels, health status, not 
currently using supplements, not using hormone replacement therapy, and one study included all 
subjects with prostate cancer scheduled for prostatectomy.
Measures
All but one of the studies used blood testing to determine the effects of the flax 
supplementation. For these studies blood was tested at induction and again at the end of the 
study, and most also tested blood at least once during the supplementation. One study by 
Barcelo-Coblijn (2008) tested blood every two weeks for the 12 week period. In most studies, 
lipid panels were measured, but individually they also tested red blood cell fatty acid content,
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insulin resistance (HOMA-ir), Hemoglobin A1C (HgA 1C), fasting glucose levels, insulin levels, 
inflammatory markers, oxidative stress markers, hormones, platelet aggregation, ALA levels, 
bone density tests, side effect journals, menopausal symptoms, and tumor proliferation markers. 
When urine was tested, it was tested for lignan metabolites to determine the amounts of flax 
consumed. Only one study, conducted by Dares-Dobbie (2006), did not measure blood or urine, 
but instead recorded bowel movements, reports of constipation, and use of pharmacologic 
interventions for bowel movements.
Approaches to Analysis
Analysis of variance (ANOVA) was used in the analysis of the data for six of the studies.
The study by Bloedon (2008) was one of those; their study included both a primary and 
secondary stance. The primary stance was the information from all of the participants, the 
secondary was the findings of the participants who adhered to the diet more than 80% of the 
time, and the results were significantly different with adherence factored in. For most of the 
studies, only data from participants who finished the study were used. Several of the studies, 
however, did not mention the dropout rate, or possible nonadherance. The Dares-Dobbie (2006) 
study did not discuss their approach to analysis. Demark-Wahnefried’s (2008) study analysis was 
based on intent to treat. Dodin (2005) and Hallund’s (2006) studies used SAS statistical 
software.
Findings
Bloedon (2008) found ALA increased and omega-six fatty acid decreased in the flax group. 
At five weeks LDL was significantly reduced compared to the control group, and at 10 weeks, 
factoring in adherence, LDL levels were still significantly reduced. HDL levels reduced in men, 
but no change in HDL was found in women, and HDL levels were unchanged in the control
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groups. There was no change in insulin sensitivity in either group. Flaxseed led to reduced 
inflammatory markers in those with hypertension, while inflammatory markers increase in the 
control group. With regard to inflammatory markers, 62% of the flax group vs. 32% of the 
control group responded favorably. Bloedon found there was a reduction in LDL at five weeks 
and it returned to baseline by 10 weeks, probably due to reduced dietary adherence. For this 
reason, the significance of this study was questioned. Further research should be done to repeat 
this study with greater methods of adherence testing, such as testing urine lignan metabolites.
Patade (2008) found that both flax groups had a total cholesterol level drop of 7%, without 
significant change in the control. LDL was reduced by 10% in the flax groups, without change in 
control group. HDL decreased by 17% in the control group, without change in the flax groups. 
Triglyceride levels increased by 18% in the control group, but only by 3% in the flax, and 8.5% 
in the flax and fiber group. Flax supplementation demonstrated no estrogenic effects. This study 
was sound, but concerns were noted. The study began with 55 subjects and ended with 42 
subjects, which calls into question whether there were enough participants to be entirely valid. 
Also, there seems to be no method of determining the adherence of the individuals other than 
through random phone questionnaires.
Lucas (2002) found that the flax group had a 6% decrease in total and non-HDL cholesterol 
levels. LDL decreased by 4.7% (not significant), and triglycerides decreased by 12.8% (also not 
significant). HDLs were somewhat lowered by flax. APOa-one and APO-b (cholesterol 
precursors) were significantly reduced by flax and unchanged by wheat. No changes were found 
in markers of bone metabolism, which meant no benefits of the phytoestrogenic lignans on bone 
metabolism were found. This was a good study that found reductions in cholesterol and
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cholesterol precursors. While LDL and Triglycerides were not reduced enough to be significant, 
their reduction is still beneficial. Lucas’ study was good with sound subject numbers and criteria.
Austria et al. (2008) found that more ALA could be absorbed from ground flax than whole 
flax. Flax oil produced the highest rise in ALA, but milled flax was almost as effective. Milled 
flax had all the benefits of fiber and lignans, and produced a three fold increase in plasma ALA 
over baseline levels. EPA and DHA did not change in the plasma lipid panels. No changes in 
platelet aggregation or bleeding times were found. No changes in lipids or cholesterol were 
found in the healthy, young, normolipidemic, normocholesterolemic men. As far as ALA 
absorption, milled flax and flax oil are highly effective flax supplements. No changes in lipid 
panels were found, possibly due to healthy participants with normal lipid values.
Barcelo-Coblijn (2008) found the consumption of ALA enriched supplements for 12 weeks 
was sufficient to elevate red blood cell levels of EPA and DHA, showing the effectiveness of 
ALA conversion. The amounts of ALA required to do this are easily achieved in the general 
population with dietary modification. There was no difference in lipid profile or plasma 
inflammatory markers between fish and flax oil groups. Fish oil groups had faster rises in 
Omega-three fatty acids in the bloodstream and the higher levels were maintained. This study 
illustrated that flax oil can produce much of the benefits produced by fish oil, however more 
research needs to be done on the effectiveness of ALA conversion to EPA and DHA, and 
whether intercellular EPA and DHA conversion in the red blood cells has the same effect as 
when dissolved in the plasma, which is measured by most lipid panels.
Demark-Wahnefried (2008) found the flax supplementation, rather than a low fat diet, 
showed positive effects in decreasing the tumor proliferation rates in men with prostate cancer. 
Tumor proliferation rates were measured by counting Ki-67 positive cells (an indication of
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cancer growth) in the prostate specimens after prostatectomy. They found that those who ate flax 
and a low fat diet had 1.50% of cells Ki-67 positive, 1.66% in the flax and regular diet group, 
and 3.23% in the regular diet control group . Only low fat diets showed effects on cholesterol, 
which may potentially be due in part to the short duration of supplementation. This study 
included the highest number of participants and had some very significant findings, but was 
limited to the short duration of the presurgical timeframe average of 21 days. More research is 
needed on the full effects of lignans in order to utilize them to their full potential.
Pan (2007) found that by supplementing people with type 2 diabetes mellitus with flax 
derived lignans, they had significantly improved HbAlc levels, which is an indication of 
glycemic control. Homa-insulin resistance was reduced by 3.3% compared to baseline. Fasting 
glucose and insulin concentration levels were also reduced, but not significantly. There were no 
changes in the lipid panels, perhaps due to the lack of fiber and ALA found in flax, but absent 
from the isolated lignans. This study had enough participants and thorough analysis to be judged 
a reputable resource, however, more studies on the benefits of lignans are needed as there is 
currently very little available.
Dares-Dobbie (2006) found that during the flax supplementation phase there were no reports 
of constipation. During supplementation there was a 95% decrease in laxative use and 42% of 
participants increased frequency of bowel movements, while 48% had decreased frequency of 
bowel movements. Results showed that, in these patients, adding flax often decreased bowel 
movements but increased ability to have bowel movements without intervention. This study was 
very limited in its resource value. While the concept is good, and the information is good, there 
was no discussion of necessary sample size, and this study was small with only 12 participants. 
More research with larger samples and more analysis is needed for flax and bowel care.
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Dodin’s (2005) study is the largest of the group, with 199 postmenopausal women spanning 
one year of supplementation. While they did not demonstrate any change in bone mineral density 
or menopausal symptoms, the women in the flaxseed group had a significant decrease in total 
cholesterol of 0.2mmol/L (or 8 mg/dL). Initially systolic and diastolic BP were both reduced by 
4 mm/Hg to 5 mm/Hg in the flax group, with no change in the placebo, but these numbers did 
not carry through to the end of the study. In addition, this study showed a slight decrease in HDL 
of 0.08mmol/L or about 3 mg/dL as well (Dodin, 2005). More study is needed in the effect of 
flax on hypertension.
Hallund (2006; 2008) produced two studies with the same study group, through testing for 
different factors; one for inflammation, and one for vascular endothelial constriction. While they 
found the C-reactive protein, a marker of inflammation, decreased by 15% through flax 
supplementation, they did not find any significant change in markers of constriction. This sample 
size was small, at 22 participants, but the results are significant and warrant further study.
In order to determine the bioavailability of the lignans found in flax, as well as, to determine 
whether the flora found in human intestinal tracts are sufficient to convert lignans into their 
usable forms, Wang et al. conducted a study in 2010. They found through culturing and isolating 
human fecal bacteria, it was possible to isolate groups of bacteria that convert flax lignans into 
potent bioavailability lignans. These bacteria were found to be more efficient and effective at 
converting flax lignans than can currently be done synthetically. This study has proven the 
effectiveness of the conversion of flax lignans in the human GI tract, as well as, the possibility of 
future commercial production of lignans through bacterial conversion.
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Findings of Reviews
Bassett, Rodriguez-Leyva, and Pierce (2009), in doing a systematic review on flax 
supplementation, reviewed 53 articles on the subject. They found that ground flaxseed could 
reduce total cholesterol 6-11%, LDL by 9-18%, and could lower markers of atherosclerotic 
cardiovascular disease. The hypocholesterolemic effect was most likely associated with the fiber 
and lignan content of the ground flax. There were also anti-inflammatory, antiatherogenic and 
antiproliferative effects of flax supplementation which were attributed to the ALA Omega-three 
fatty acids. This review supported the idea that ALA is a cardioprotective Omega-three fatty 
acid, like EPA and DHA from fish oil. This review also suggested further study of flax 
supplementation in patients with atherosclerosis.
Prasad et al. completed a review of flax supplementation in 2009 which references 96 articles 
on the subject of flax supplementation and cardiovascular disease. Their findings suggested that 
flaxseed constituents such as fiber and lignan, but not flax oil, can suppress atherosclerotic heart 
disease, but can’t regress it. They linked the suppressive effects to the lignan rather than the ALA 
content of flax. They found that flax that is low in ALA, and lignans can significantly lower lipid 
levels, but these effects are variable. ALA in high doses suppressed inflammation, decreased 
platelet aggregation and increased bleeding time. Their findings suggested that the components 
of flaxseed may be effective in cardiovascular health.
Pan, Yu, Demark-Wahnefried, Faranco, and Lin, in their 2009 review, critiqued 28 
studies spanning the last 20 years in order to compile the proven effects of flax derived 
supplements on lipids. This review found whole flaxseed reduced LDL by 0.21 mmol/L and 0.16 
mmol/L, flax lignans reduced LDL by 0.28 mmol/L and 0.16 mmol/L, but flaxseed oil showed
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no effect on LDL. They did not find that any flax derived intervention effected HDL or 
triglycerides significantly.
Characteristics of individual studies included in this paper are presented in Table A1 
Summary o f Study Characteristics (Appendix), which lists studies by author and includes the 
types of study designs used, conclusions of each of the studies, and comments and opinions 
about each of the studies.
Methods
This review began with searches on several databases, mainly CINAHL, PubMed, and 
Google Scholar. Keywords used in the search included flax, flaxseed, Omega-three Fatty acids, 
cholesterol, ALA, and cardiovascular disease. When possible, the limitations of Peer Reviewed, 
PDF full text available, human studies, trial studies and English language were used. The initial 
searches in CINAHL resulted in very limited results yielding only five usable articles, however, 
PubMed had many more. Google scholar results brought up many of the same articles from 
PubMed and CINAHL, but few were able to be accessed. Through the searches, many relevant 
articles were found. Using the references from several of those articles led to the retrieval of 
several others that had not originally shown up in the searches.
Researching flax supplementation the main focus was on articles and studies that, in general, 
compared flax to a control which consisted of substances known to have little benefit in 
cholesterol management, such as wheat bran. In using these studies, any effects of the flax 
should be clear when compared against the control, as the control should have no significant 
effect of its own. Few studies were included that compared flax to another treatment modality 
such as fish oil. One such study did compare the two, but had flax as the primary focus and did 
not diminish the flax oil effects. Only human trials were included. Not all studies had a control,
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but the ones selected for this review were current, and involved flax supplementation in the form 
of whole flaxseed, ground flax, flax oil, or flax derived lignan.
A poster was created which basically provided a summary of the review as of April 2010. 
This poster was completed with an overview of the reasons that flax is being studied, which 
included the potential benefits of ALA, lignans, the soluble and insoluble fiber, and the best form 
in which to supplement flax. An in-depth review of the studies reviewed was also included. The 
proven benefits of flax supplementation were highlighted along with considerations for practice 
and intentions for a final product.
Results
In order to determine the effectiveness of the pamphlet, it was posted to an evidence based 
practice graduate level nursing class blog. The purpose of this was to obtain peer reviews of not 
only the pamphlets presentation, but of the content as well. In total, five peers viewed and 
commented on the pamphlet. Most comments were very positive, with several constructive 
comments on the need to reduce the information posted in the body of the pamphlet. These 
comments were taken into consideration and edits were made to make the pamphlet easier to 
read and comprehend.
Using the information found in this review and the pamphlet created, education will be 
provided to both patients and colleagues on the benefits and indications for flax supplementation. 
This information will be introduced into practice and both this review and the pamphlet will be 
available for patients and practitioners to use at their discretion. Also, this information can be 
used to create and present a presentation about flax supplementation geared towards either 
patients or providers.
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Discussion and Implications for Nursing
Practice
The findings of the studies reviewed indicated there is great potential for flax 
supplementation with regards to cholesterol management. Studies have shown modest 
improvement in both total cholesterol, and LDL cholesterol through flax supplementation. For 
this reason practitioners should advise the addition of flax in the diets of patients who wish to 
maintain a normal cholesterol level, as well as, those who need to reduce their LDL cholesterol.
For patients who use pharmacologic bowel regulation measures, trialing flax 
supplementation in lieu of pharmaceutical methods could be suggested. While the bowel health 
study reviewed was limited in its size and analysis, the findings were valid. Personal experience 
supplementing the diet with ground flax can have tremendous abilities in the prevention of 
constipation, with fewer episodes of gastronomic disturbance and flatulence than many high- 
fiber foods on the market today.
Research
While the findings of the studies have proven there are benefits to flax supplementation, the 
full extent of the benefits are not fully understood. This is especially true of the benefits of 
lignans found in the flaxseed. Flax has the highest concentration of lignans of any organic food 
source. Additional questions regarding flax lignans include: how beneficial are lignans? What 
health conditions can lignans provide protection from? and what conditions are they able to 
treat? In order to answer these questions more research is required.
In addition, the full effects of the ALA found in flax are still not fully understood. More 
research is needed in order to determine the body’s abilities to utilize ALA for a significant 
benefit. Debate also continues about the cholesterol lowering abilities of flax being either an
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ALA or lignan/fiber benefit. These questions need to be answered and the only way to 
accomplish that is through more research.
The final area of flax supplementation that has greatly overlooked potential is the bowel 
management properties of the fiber found in flax. The one study reviewed was very small in 
sample size and low in analytical discussion, the results were very clear, but more study is 
needed to determine just how effective flax supplementation is in treatment of constipation and 
bowel regulation. From personal experience supplementing a diet with flax, it has tremendous 
abilities in the prevention of constipation. However more research showing its full effectiveness 
would be very beneficial.
Education
Education on dietary modification is necessary in order to promote inclusion of flax in the 
diet. Ground flax has a relatively short shelf life, and must be used or frozen within a month after 
grinding or opening. Also, it is necessary to start with a small amount of flax and increase to a 
total of two to four tablespoons per day in order to acclimate to the large amount of fiber without 
abdominal discomfort. Adequate hydration is necessary with all high-fiber diets in order to 
prevent constipation.
Ways in which to include flax in the diet are often simple, such as adding ground flax to 
yogurt, cereal, or oatmeal. It can also be mixed in condiments such as mustard or mayonnaise 
and used in a sandwich. It can be used in baking as well, either as an addition to the ingredients, 
or as a substitute for eggs or cooking oil. One tablespoon of ground flax with three tablespoons 
of warm water, when mixed and allowed to sit, can be substituted for an egg (Buse et al., 2009). 
One cup of flax flour can replace one-third cup of cooking oil (Children’s Better Health Institute, 
2005). Imagine the health benefits of using less cooking oil and more flax in our everyday diet.
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Flax should be a mainstay in baked goods; all it takes is a little education on our part and the 
parts of dieticians in order to get more people to consume more flax.
Health Policy
Flax supplementation would not require much in the way of health policy change, rather the 
extent of its benefits are in need of further study, and more dietary inclusion. Once flax benefits 
are fully known, it could become a staple health food that would be recommended in many areas 
of healthcare. Policy should not be affected except in facilities whose policies would change in 
order to include flax in their diet.
Summairy/Conclusions
In conclusion, flax supplementation is a topic of debate for good reasons. It has been 
linked to improved cardiovascular health through the anti-inflammatory, antiatherogenic and 
antiproliferative properties of ALA. Also, it has anticholesterolemic properties through ingestion 
of the lignans and fiber. The full benefit of ALA and lignans in humans is still not fully 
understood, but additional research should determine the full extent of ALA function and use.
The cardiovascular effects of flax supplementation are only the tip of the iceberg as far as the 
potential benefits of flax goes. Flax also has tremendous potential for beneficial effects on bowel 
management, diabetes management, and reduction of tumor proliferation rates. Some of these 
benefits are not fully understood and will require additional research in order to determine the 
extent of the benefits and what conditions may benefit from flax supplementation. 
Phytoestrogenic effects were not shown in any of the studies reviewed, so flax should neither be 
used for nor contraindicated by phytoestrogenic effects.
Flax supplementation shows great promise. Currently there is sufficient evidence showing 
that flax has benefits for both cardiovascular health, in the form of cholesterol management, and
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bowel health, in constipation management. Among flax supplementation, ground flax is 
considered the best medium of supplementation due to the availability of the ALA to be 
absorbed easily, as well as, the presence of the fiber and lignans.
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Summary o f Study Characteristics Table
Author(s),
Year
Description of Study Conclusions Comments
Bloedon, L., 
et al. (2008).
Randomized clinical trial 
using 62 men and post 
menopausal women. 
Randomly given 40g/day of 
flax supplementation.
Ground flaxseed has a 
modest but short lived 
LDL-C lowering effect, 
yet reduces inflammatory 
markers and improves 
insulin sensitivity in 
hyperlipidemic adults. The 
HDL-C lowering effect of 
flaxseed in men warrants 
additional study.
Good study with 
clinical testing but 




Randomized clinical trial 55 
female Native American 
postmenopausal women 
with hypercholesterolemia 
given 30g flaxseed, oat 
bran+ flaxseed, or a control 
supplementation for three 
months.
Results in flaxseed group 
showed a 7-10% decrease 
in LDL levels. HDL and 
triglycerides remained 
unchanged.
Good article, good 
sample, and good 
time frame.
Lucas, E., et 
al. (2002).
Randomized clinical trial, 
58 postmenopausal women 
consumed 40g of flax or 
wheat substitute daily for 
three months.
Flaxseed supplementation 
lowered total cholesterol, 
and non-HDL. The 
control regimen had no 
effect. Flaxseed regimen 
reduced serum levels of 
both LDL and HDL. Bone 
formation markers not 
affected by
phytoestrogenic effects of 
flaxseed supplementation.
Good study covering 
a longer study period 
and higher number of 
subjects than the 
study by Hallund.
Austria, J. et 
al. (2008)
30 healthy volunteers ages 
18-49 randomly assigned to 
three treatment groups, 
ingesting whole flax seed, 
milled flax seed and flax 
seed oil in baked goods. 
Over a period of 12 weeks.
Were able to extract more 
ALA from ground flax 
than flax. Oil produced 
highest rise in ALA, but 
has low shelf life. Milled 
flax has all the benefits of 
fiber and lignans with 
three times the increase in
Gastrointestinal 
disturbances found to 
hinder compliance in 
whole seed group.
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plasma ALA. EPA and 
DHA did not change. No 
change in platelet 
aggregation or bleeding 





Study involving six groups 
consisting of 9-12 Winnipeg 
firefighters over age 40 not 
on medication, exercising, 
and eating a high fat diet. 
Control group had 1 g 
sunflower oil supplement. 
Flax oil groups were 
supplemented with 
1.2g/day, 2.4g/day, or 3.6 
g/day. Fish oil groups 
supplemented with 0.6g/day 
or 1,2g/day. Blood was 
tested every two weeks for 
12 weeks. Study protocol 
approved by UND and 
blood samples tested at 
UND.
The consumption of ALA 
enriched supplements for 
12 weeks was sufficient to 
elevate red blood cell 
levels of EPA and DHA 
showing the effectiveness 
of ALA conversion. The 
amounts of ALA required 
to do this are easily 
achieved in the general 
population with dietary 
modification. There was 
no difference in lipid 
profile or plasma 
inflammatory markers 
between fish and flax oil 
groups.
Shows that ALA can 
be effective like fish 
oil. However, found 
fish oil increases 
levels more quickly 
and maintain levels 





clinical trial to test effects of 
a regular diet, a low fat diet, 
low fat diet with flax seed 
supplementation or flax seed 
supplementation with a 
regular diet on 161 
individuals with prostate 
cancer prior to 
prostatectomy. Average 30 
days from initiation to end 
point. Levels were measured 
for PSA, LDL, cholesterol, 
testosterone, insulin-like 
growth factor-one, and the 
tumor marker Ki-67. 149 
participants finished the 
study.
The flax groups had 
significantly lower tumor 
proliferation rates which 
were 1.5 For flax and low 
fat, 1.66 for regular diet 
and flax, 3.2 for the 
regular diet without flax, 
and 2.56 for the low fat 
diet without flax. 
Cholesterol decreased in 
low fat diet.
Flax may be protective 
against prostate cancer.
Large study sample, 
short time frame, 





Non randomized clinical 
trial of flax supplementation 
in food cooked in a nursing 
home for willing
Laxative use decreased by 
95% during flax 
supplementation. Half had 
increased bowel
Very interesting 
study with enormous 
potential for impact 
in the elderly
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participants, comparison of 
bowel movements, PRN 
laxative use, over a month’s 
time before and after flax 
supplementation.
movements with flax, half 
had fewer. None reported 
constipation during the 
flax supplementation.
population. Also a 
great benefit for those 
with bowel 
irregularity. Good 
study on secondary 
benefits of flax.
Pan, A., et 
al. (2007)
Randomized, double-blind, 
cross-over trial for the use 
of flax lignan supplement on 
type two diabetics. 37 took a 
360mg flax lignan pill and 
36 took a placebo for 12 
weeks, took eight weeks off 
then the groups switched for 
12 weeks. Urine tests 
validated adherance in 
lignan group.
Lignans reduced Homa- 
insulin resistance by 3.3% 
compared to baseline. 
Fasting glucose and 
insulin concentration were 
also reduced, but not 
significantly. By week 12 
HgAlc was significantly 
reduced.
Study had good 
findings, and 
information regarding 
why they chose the 
number of 
participants and how 




A randomized double-blind 
clinical study in which 199 
healthy menopausal women 
were assigned to 40 g flax 
or wheat germ placebo for 
12 months. Menopausal 
symptoms, lipids, and bone 
mineral density at were 
recorded at onset and at 12 
months.
Flaxseed reduced total 
choleseterol,0.2 mmol/L, 
and HDL 0.08 mmol/L. 
There was no change in 
bone mineral density. 
Similar reductions in 
menopausal symptoms 
were found in both 
placebo and flax groups.
Good size and 
duration of study, 





placebo controlled crossover 
study in which 22 
postmenopausal women ate 
muffins daily with or 
without the flax derived 
lignans. Blood draws were 
taken to measure markers of 
vascular endothelial 
constriction.
This study showed no 
significant change in the 
markers of vascular 
constriction.
Small sample size, 
but otherwise good 
study, shows that 







placebo controlled crossover 
study in which 22 
postmenopausal women ate 
muffins daily with or 
without the flax derived 
lignans. Blood draws were 
taken to measure C-reactive
This study did show a 
significant difference of 
15% in CRP levels from 
the flax lignan group in 
comparison to the placebo 
group.
Small sample size, 
but otherwise good 
study, shows that 
lignans probably do 
reduce inflammation.
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Clinical trial of producing 
enterodiol, an effective 
antioxidant from defatted 
flax seeds by using human 
intestinal bacteria.
This study found that the 
intestinal bacteria cultured 
from fecal matter of 
healthy young adults, is an 
effective, efficient and 
eco-friendly way to 
convert flax lignans to 
enterodiol, a potent 
antioxidant.
This clinical trial 
isolated the bacteria 
in order to determine 
which combination of 
bacteria yields 
enterodiol.
Pan, A., et 
al. (2009)
Literature review including 
28 studies dating from 
1990-2008. Review covered 
whole flax seed, flax 
derived lignans and flax 
seed oil supplements effect 
on adult lipid profiles.
Flaxseed interventions 
reduced total LDL 
concentrations by 0.1 and 
0.08 mmol/L, Whole 
flaxseed by 0.21 and 0.16 
mmol/L, flax lignans by 
0.28 and 0.16 mmol/L, but 
flaxseed oil showed no 
effect on LDL. No flax 
derived intervention had 
significant effect on HDL 
or triglycerides.
This review was 
fairly comprehensive 
and used the Jadad 
score in order to 




Review of clinical dietary 
intervention trials. 53 
references.
Evidence suggests that 
ALA and lignans provide 
hypercholesterolemic 
action. ALA contributes to 
the antiatherogenic effects 





covering many of 
above articles as well 
as many more that 




Review of studies on the 
effectiveness of flax seed 
supplementation on 
cholesterol in humans and 
animals. Discusses contents 
of flax including cyanide. 
Eating one kg per day could 
cause problems in regards to 
cyanide toxicity.
Flaxseed, not flax oil can 
suppress the development 
of atherosclerosis, but do 
not regress
atherosclerosis. Flaxseed 
oil in large quantities can 
suppress inflammatory 
mediators and decreases 
platelet aggregation. 
Flaxseed oil may interact 
with anticoagulants. 




good and bad 
qualities of flaxseed 
supplementation.
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Why consider flax 
supplementation!*
Like fish oil, flax is high in 
omega-3fatty acids. However 
flax also contains fiber, lignans 
which can act as antioxidants, 
and are a good option for those 
allergic to fish.
Flax can help lower cholesterol.
Flax can help prevent 
constipation.
Flax has potential to reduce 
systemic inflammation.
F.asy to supplement and 
incorporate in diet.
Flax Bread
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Benefits of flaxseed 
supplementation.
• Ground flax supplementation is 
proven to:
• Lower total cholesterol by as much
as 6-11%.
• lowers LDL cholesterol by as much
as 6-18%.
• Reduce incidences of constipation 
and. need for laxative use.
• Improve markers of systemic 
inflammation.
Ground Flax
Flaxseed before and after grinding.
How to supplement with 
flaxseed.
Flax is belt supplemented at ground flax and 
flax flour as it has a fibrous shell that must be 
broken before the contents can be digested.
Flaxseed contains a large amount o f fiber, 
when you start to use flax start with one tea­
spoon of flax flour, and gradually increase up 
to  2 tablespoons to  avoid gas o r abdominal 
discomfort.
Flax flour can go rancid faster than tegular 
flour, for this reason it may be best to  buy 
whole flaxseed which has a long shelf life 
then grind it in a coffee grinder prior to  use.
Flax flour will last longer if stored in the
Tips for supplementing with 
flaxseed.
Add ground flax o r flax flour to  cold cereal, 
yogurt, oatmeal, o r condiments such as 
ketchup , mustard, o r mayonnaise.
Replace 1 /  i  cup o f oil with one cup 
of flax flour in baked goods.
Replace Eggs in baked goods by combining 
1 tablespoon o f Giouud Flax with J table­
spoons o f water, le t it sit for a few minutes 
before adding.
Flax Buns
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